Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioLine Rx

3.71
-0.0600-1.59%
Post-market: 3.710.00000.00%19:16 EDT
Volume:19.36K
Turnover:71.31K
Market Cap:13.80M
PE:-2.70
High:3.81
Open:3.65
Low:3.62
Close:3.77
52wk High:32.26
52wk Low:2.30
Shares:3.72M
Float Shares:3.54M
Volume Ratio:0.44
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3764
EPS(LYR):-4.6176
ROE:-45.94%
ROA:-15.36%
PB:0.69
PE(LYR):-0.80

Loading ...

UPDATE: BioLine Rx Q2 EPADS $(1.00) Beats $(1.20) Estimate, Sales $304.000K Miss $924.000K Estimate

Benzinga
·
Aug 14

BioLineRx Had Cash, Cash Equivalents, And Short-term Bank Deposits Of $28.2M, Sufficient To Fund Operations, As Currently Planned, Into 1H Of 2027

Benzinga
·
Aug 14

BioLine Rx Q2 2025 EPS $(0.00) Beats $(1.20) Estimate, Sales $304.000K Miss $924.000K Estimate

Benzinga
·
Aug 14

BioLine RX Ltd expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
Aug 12

BioLine RX Price Target Maintained With a $26.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 17

BioLine RX Raised to Buy From Hold by Jones Trading

Dow Jones
·
May 30

Bioline Says Pilot Study of Potential Pancreatic Cancer Drug Combo Shows Improved Overall Response Rate; Shares Soar Pre-Bell

MT Newswires Live
·
May 30

Top Premarket Gainers

MT Newswires Live
·
May 30

JonesTrading Reaffirms Their Hold Rating on Bioline RX Ltd Sponsored ADR (BLRX)

TIPRANKS
·
May 28

BioLine RX Price Target Maintained With a $26.00/Share by HC Wainwright & Co.

Dow Jones
·
May 28

BioLine Rx Q1 2025 EPS $0.00 May Not Be Comparable To $(1.20) Estimate, Sales $255.00K Vs. $6.86M YoY

Benzinga
·
May 27

Press Release: BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update

Dow Jones
·
May 27

BioLine RX Ltd expected to post a loss of 93 cents a share - Earnings Preview

Reuters
·
May 23

BLRX: 2024 Financial Results

Zacks Small Cap Research
·
Apr 03

BioLine Rx Ltd (BLRX) Q4 2024 Earnings Call Highlights: Strategic Licensing and Market ...

GuruFocus.com
·
Apr 03

BioLine RX Cut to Hold From Buy by Jones Trading

Dow Jones
·
Apr 02

BioLineRx downgraded to Hold from Buy at JonesResearch

TIPRANKS
·
Apr 02

JonesTrading downgrades Bioline RX Ltd Sponsored ADR (BLRX) to a Hold

TIPRANKS
·
Apr 02

BioLine RX Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 01

Options Volatility and Implied Earnings Moves Today, March 31, 2025

TIPRANKS
·
Mar 31